296
Views
1
CrossRef citations to date
0
Altmetric
Musculoskeletal

Safety of a single intra-articular injection of LBSA0103 hyaluronic acid in patients with osteoarthritis of the knee: a multicenter, single-arm, prospective, cohort study

, , , , , , , & show all
Pages 1573-1580 | Received 27 Dec 2020, Accepted 16 Jun 2021, Published online: 15 Jul 2021

References

  • Lane NE, Brandt K, Hawker G, et al. OARSI-FDA initiative: defining the disease state of osteoarthritis. Osteoarthritis Cartilage. 2011;19(5):478–482.
  • Musumeci G, Carnazza ML, Loreto C, et al. β-Defensin-4 (HBD-4) is expressed in chondrocytes derived from normal and osteoarthritic cartilage encapsulated in PEGDA scaffold. Acta Histochem. 2012;114(8):805–812.
  • Jang S, Lee K, Ju JH. Recent updates of diagnosis, pathophysiology, and treatment on osteoarthritis of the knee. IJMS. 2021;22(5):2619.
  • Katz JN, Arant KR, Loeser RF. Diagnosis and Treatment of Hip and Knee Osteoarthritis: A Review. . 2021; Feb 9325(6):568–578.
  • Brown GA. AAOS clinical practice guideline: treatment of osteoarthritis of the knee: evidence-based guideline, 2nd edition. J Am Acad Orthop Surg. 2013; Sep21(9):577–579.
  • Musumeci G, Trovato FM, Loreto C, et al. Lubricin expression in human osteoarthritic knee meniscus and synovial fluid: a morphological, immunohistochemical and biochemical study. Acta Histochem. 2014; Jun116(5):965–972.
  • Heidari B. Knee osteoarthritis prevalence, risk factors, pathogenesis and features: part I. Caspian J Intern Med. 2011;2(2):205–212.
  • Zhang YQ, Jordan JM. Epidemiology of osteoarthritis. Clin Geriatr Med. 2010;26(3):355–369.
  • Litwic A, Edwards MH, Dennison EM, et al. Epidemiology and burden of osteoarthritis. Br Med Bull. 2013;105:185–199.
  • Araujo IL, Castro MC, Daltro C, et al. Quality of life and functional independence in patients with osteoarthritis of the knee. Knee Surg Relat Res. 2016;28(3):219–224.
  • Tsonga T, Michalopoulou M, Malliou P, et al. Analyzing the history of falls in patients with severe knee osteoarthritis. Clin Orthop Surg. 2015;7(4):449–456.
  • Primorac D, Molnar V, Matisic V, et al. Comprehensive review of knee osteoarthritis pharmacological treatment and the latest professional societies' guidelines. Pharmaceuticals. 2021;14(3):205.
  • Musumeci G, Loreto C, Leonardi R, et al. The effects of physical activity on apoptosis and lubricin expression in articular cartilage in rats with glucocorticoid-induced osteoporosis. J Bone Miner Metab. 2013;31(3):274–284.
  • Zampogna B, Papalia R, Papalia GF, et al. The role of physical activity as conservative treatment for hip and knee osteoarthritis in older people: a systematic review and meta-analysis. JCM. 2020;9(4):1167.
  • Harirforoosh S, Asghar W, Jamali F. Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications. J Pharm Pharm Sci. 2013;16(5):821–847.
  • Bowman EN, Hallock JD, Throckmorton TW, et al. Hyaluronic acid injections for osteoarthritis of the knee: predictors of successful treatment. Int Orthop. 2018;42(4):733–740.
  • Richette P. Hyaluronic acid: Still useful in knee osteoarthritis? Joint Bone Spine. 2017;84(6):655–656.
  • Castrogiovanni P, Di Rosa M, Ravalli S, et al. Moderate physical activity as a prevention method for knee osteoarthritis and the role of synoviocytes as biological key. IJMS. 2019;20(3):511.
  • Band PA, Heeter J, Wisniewski HG, et al. Hyaluronan molecular weight distribution is associated with the risk of knee osteoarthritis progression. Osteoarthritis Cartilage. 2015;23(1):70–76.
  • Kobayashi T, Chanmee T, Itano N. Hyaluronan: metabolism and function. Biomolecules. 2020;10(11):1525.
  • Altman R, Bedi A, Manjoo A, et al. Anti-inflammatory effects of intra-articular hyaluronic acid: a systematic review. Cartilage. 2019;10(1):43–52.
  • Altman R, Hackel J, Niazi F, et al. Efficacy and safety of repeated courses of hyaluronic acid injections for knee osteoarthritis: a systematic review. Semin Arthritis Rheum. 2018;48(2):168–175.
  • Migliore A, Procopio S. Effectiveness and utility of hyaluronic acid in osteoarthritis. Clin Cases Miner Bone Metab. 2015;12(1):31–33.
  • Bowman S, Awad ME, Hamrick MW, et al. Recent advances in hyaluronic acid based therapy for osteoarthritis. Clin Transl Med. 2018;7(1):6.
  • Ha CW, Park YB, Choi CH, et al. Efficacy and safety of single injection of cross-linked sodium hyaluronate vs. three injections of high molecular weight sodium hyaluronate for osteoarthritis of the knee: a double-blind, randomized, multi-center, non-inferiority study. BMC Musculoskelet Disord. 2017;18(1):223.
  • Lee JK, Choi CH, Oh KJ, Kyung HS, et al. Safety and efficacy of bi-annual intra-articular LBSA0103 injections in patients with knee osteoarthritis. Rheumatol Int. 2017;37(11):1807–1815.
  • Soltes L, Mendichi R, Kogan G, et al. Degradative action of reactive oxygen species on hyaluronan. Biomacromolecules. 2006;7(3):659–668.
  • Larsen NE, Dursema HD, Pollak CT, et al. Clearance kinetics of a hylan-based viscosupplement after intra-articular and intravenous administration in animal models. J Biomed Mater Res B Appl Biomater. 2012;100(2):457–462.
  • Chevalier X, Jerosch J, Goupille P, et al. Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial. Ann Rheum Dis. 2010;69(1):113–119.
  • Petterson SC, Plancher KD. Single intra-articular injection of lightly cross-linked hyaluronic acid reduces knee pain in symptomatic knee osteoarthritis: a multicenter, double-blind, randomized, placebo-controlled trial. Knee Surg Sports Traumatol Arthrosc. 2019;27(6):1992–2002.
  • Boutefnouchet T, Puranik G, Holmes E, et al. Hylan GF-20 viscosupplementation in the treatment of symptomatic osteoarthritis of the knee: clinical effect survivorship at 5 years. Knee Surg Relat Res. 2017;29(2):129–136.
  • De Boulle K, Glogau R, Kono T, et al. A review of the metabolism of 1,4-butanediol diglycidyl ether-crosslinked hyaluronic acid dermal fillers. Dermatol Surg. 2013;39(12):1758–1766.
  • Ma X, Xu T, Chen W, et al. Injectable hydrogels based on the hyaluronic acid and poly (γ-glutamic acid) for controlled protein delivery. Carbohydr Polym. 2018;179:100–109.
  • Xue Y, Chen HY, Xu C, et al. Synthesis of hyaluronic acid hydrogels by crosslinking the mixture of high-molecular-weight hyaluronic acid and low-molecular-weight hyaluronic acid with 1,4-butanediol diglycidyl ether. RSC Adv. 2020;10(12):7206–7213.
  • Yang B, Guo X, Zang H, et al. Determination of modification degree in BDDE-modified hyaluronic acid hydrogel by SEC/MS. Carbohydr Polym. 2015;131:233–239.
  • Hunter DJ. Viscosupplementation for osteoarthritis of the knee. N Engl J Med. 2015;372(11):1040–1047.
  • Maheu E, Rannou F, Reginster JY. Efficacy and safety of hyaluronic acid in the management of osteoarthritis: Evidence from real-life setting trials and surveys. Semin Arthritis Rheum. 2016;45(4 Suppl):S28–S33.
  • Bannuru RR, Osani M, Vaysbrot EE, et al. Comparative safety profile of hyaluronic acid products for knee osteoarthritis: a systematic review and network meta-analysis. Osteoarthritis Cartilage. 2016;24(12):2022–2041.
  • Bannuru RR, Brodie CR, Sullivan MC, et al. Safety of repeated injections of sodium hyaluronate (SUPARTZ) for knee osteoarthritis: a systematic review and meta-analysis. Cartilage. 2016;7(4):322–332.
  • Honvo G, Reginster JY, Rannou F, et al. Safety of intra-articular hyaluronic acid injections in osteoarthritis: outcomes of a systematic review and meta-analysis. Drugs Aging. 2019;36(Suppl 1):101–127.
  • Trigkilidas D, Anand A. The effectiveness of hyaluronic acid intra-articular injections in managing osteoarthritic knee pain. Ann R Coll Surg Engl. 2013;95(8):545–551.
  • Miller LE, Fredericson M, Altman RD. Hyaluronic acid injections or oral nonsteroidal anti-inflammatory drugs for knee osteoarthritis: systematic review and meta-analysis of randomized trials. Orthop J Sports Med. 2020;8(1):232596711989790.
  • Bruyere O, Cooper C, Pelletier JP, et al. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Semin Arthritis Rheum. 2014;44(3):253–263.
  • McAlindon TE, Bannuru RR, Sullivan MC, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014;22(3):363–388.
  • Trojian TH, Concoff AL, Joy SM, et al. AMSSM scientific statement concerning viscosupplementation injections for knee osteoarthritis: importance for individual patient outcomes. Clin J Sport Med. 2016;26(1):1–11.
  • Intra-articular hyaluronan injections for treatment of osteoarthritis of the knee. Tecnologica MAP Suppl. 1998:6–10.
  • Arden NK, Perry TA, Bannuru RR, et al. Non-surgical management of knee osteoarthritis: comparison of ESCEO and OARSI 2019 guidelines. Nat Rev Rheumatol. 2021;17(1):59–66.
  • Idrissi Z, Benbouazza K, Fourtassi M, et al. Acute pseudo-septic arthritis following viscosuplementation of the knee. Pan Afr Med J. 2012;12:44.
  • Albert C, Brocq O, Gerard D, et al. Septic knee arthritis after intra-articular hyaluronate injection. Two case reports. Joint Bone Spine. 2006;73(2):205–207.
  • Aydin M, Arikan M, Togral G, et al. Viscosupplementation of the knee: three cases of acute pseudoseptic arthritis with painful and irritating complications and a literature review. Eur J Rheumatol. 2017;4(1):59–62.
  • Shemesh S, Heller S, Salai M, et al. Septic arthritis of the knee following intraarticular injections in elderly patients: report of six patients. Isr Med Assoc J. 2011;13(12):757–760.
  • de Rezende MU, de Campos GC. Viscosupplementation. Rev Bras Ortop. 2012;47(2):160–164.
  • Ong KL, Runa M, Xiao Z, et al. Severe acute localized reactions following intra-articular hyaluronic acid injections in knee osteoarthritis. Cartilage. 2020:1947603520905113.
  • Kenne L, Gohil S, Nilsson EM, et al. Modification and cross-linking parameters in hyaluronic acid hydrogels-definitions and analytical methods. Carbohydr Polym. 2013;91(1):410–418.
  • Al-Sibani M, Al-Harrasi A, Neubert RH. Study of the effect of mixing approach on cross-linking efficiency of hyaluronic acid-based hydrogel cross-linked with 1,4-butanediol diglycidyl ether. Eur J Pharm Sci. 2016;91:131–137.
  • Lan SM, Jou IM, Wu PT, et al. Investigation into the safety of perineural application of 1,4-butanediol diglycidyl ether-crosslinked hyaluronan in a rat model. J Biomed Mater Res B Appl Biomater. 2015;103(3):718–726.
  • Berkoff DJ, Miller LE, Block JE. Clinical utility of ultrasound guidance for intra-articular knee injections: a review. Clin Interv Aging. 2012;7:89–95.
  • Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986;29(8):1039–1049.
  • Kohn MD, Sassoon AA, Fernando ND. Classifications in brief: Kellgren-Lawrence classification of osteoarthritis. Clin Orthop Relat Res. 2016;474(8):1886–1893.
  • Åkermark C, Berg P, Björkman A, et al. Non-animal stabilised hyaluronic acid in the treatment of osteoarthritis of the knee – a tolerability study. Clin Drug Invest. 2002;22(3):157–166.
  • Migliore A, Frediani B, Gigliucci G, et al. Efficacy of a single intra-articular HYMOVIS ONE injection for managing symptomatic hip osteoarthritis: a 12-month follow-up retrospective analysis of the ANTIAGE register data. Orthop Res Rev. 2020;12:19–26.
  • Leopold SS, Warme WJ, Pettis PD, et al. Increased frequency of acute local reaction to intra-articular hylan GF-20 (synvisc) in patients receiving more than one course of treatment. J Bone Joint Surg Am. 2002;84(9):1619–1623.
  • Cheecharean S, Kesorn K. The accuracy of intra-articular needle placements in osteoarthritic knee patients: an arthroscopic assessment. J Med Assoc Thai. 2016;99(7):803–810.
  • Pullman-Mooar S, Mooar P, Sieck M, et al. Are there distinctive inflammatory flares after hylan g-f 20 intraarticular injections? J Rheumatol. 2002;29(12):2611–2614.
  • Goldberg VM, Coutts RD. Pseudoseptic reactions to hylan viscosupplementation: diagnosis and treatment. Clin Orthop Relat Res. 2004;(419):130–137.
  • Bernardeau C, Bucki B, Liote F. Acute arthritis after intra-articular hyaluronate injection: onset of effusions without crystal. Ann Rheum Dis. 2001;60(5):518–520.
  • Roos J, Epaulard O, Juvin R, et al. Acute pseudoseptic arthritis after intraarticular sodium hyaluronan. Joint Bone Spine. 2004;71(4):352–354.
  • Tahiri L, Benbouazza K, Amine B, et al. Acute pseudoseptic arthritis after viscosupplementation of the knee: a case report. Clin Rheumatol. 2007;26(11):1977–1979.
  • Lee SY, Gn KK, Chung BJ, et al. Anterolateral portal is less painful than superolateral portal in knee intra-articular injection. Knee Surg Relat Res. 2015;27(4):228–232.
  • Telikicherla M, Kamath SU. Accuracy of needle placement into the intra-articular space of the knee in osteoarthritis patients for viscosupplementation. J Clin Diagn Res. 2016;10(2):RC15–Rc17.
  • Hermans J, Bierma-Zeinstra SMA, Bos PK, et al. The most accurate approach for intra-articular needle placement in the knee joint: a systematic review. Semin Arthritis Rheum. 2011;41(2):106–115.
  • Hussein M. An accurate full-flexion anterolateral portal for needle placement in the knee joint with dry osteoarthritis. J Am Acad Orthop Sur. 2017;25(7):E131–E37.
  • Im SH, Lee SC, Park YB, et al. Feasibility of sonography for intra-articular injections in the knee through a medial patellar portal. J Ultrasound Med. 2009;28(11):1465–1470.
  • Hurdle MF, Wisniewski SJ, Pingree MJ. Ultrasound-guided intra-articular knee injection in an obese patient. Am J Phys Med Rehabil. 2012;91(3):275–276.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.